An interventional study of Ultrasound in Labor Pain, sponsored by Samuel Lunenfeld Research Institute, Mount Sinai Hospital. Recruiting at 1 site in Canada. Open to female participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-16.
Sponsored by Samuel Lunenfeld Research Institute, Mount Sinai Hospital · Not applicable, Interventional, and Diagnostic
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 22 studies in Labor Pain by Samuel Lunenfeld Research Institute, Mount Sinai Hospital — 3 open to participants now, 3 under way, none of them phase 3. Labor Pain · Samuel Lunenfeld Research Institute, Mount Sinai Hospital.
Among the 22 studies in Labor Pain by Samuel Lunenfeld Research Institute, Mount Sinai Hospital, this one is the 6th largest by planned enrollment of the 15 interventional ones that give a count, is one of 2 that started in 2024, is one of 15 with no phase, and was the 21st registered.
426 studies on the registry are indexed under Labor Pain; 76 are open to participants now.
Browse Labor Pain studies →3 of the 22 studies in Labor Pain by Samuel Lunenfeld Research Institute, Mount Sinai Hospital are open now, in 1 country. Recruiting first, the newest first:
Samuel Lunenfeld Research Institute, Mount Sinai Hospital · Sites in Canada
Ages 18–55 · Women only · Healthy volunteers
Samuel Lunenfeld Research Institute, Mount Sinai Hospital · Sites in Canada
Ages 18–50 · Women only · Healthy volunteers
By country, each count listing its studies:
Of the 31 Labor Pain studies recruiting now, 8 (26%) set no upper age limit and 23 (74%) stop at 75 or younger; 3 take children under 18; 20 take healthy volunteers.
This study: 18 Years to 50 Years · female · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
22 studies; the count open now beside each. This study's row is marked.
First in 2007; this study’s year is marked. 2 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 54 is below the median of 100 across 349 interventional studies indexed under Labor Pain.
Median enrollment 40 across the 15 interventional studies, 30 across the 7 observational. Of the 19 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Samuel Lunenfeld Research Institute, Mount Sinai Hospital is the lead sponsor of 138 studies on the registry; 17 are open to participants now.
2 of the studies in Labor Pain by Samuel Lunenfeld Research Institute, Mount Sinai Hospital that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06572241Samuel Lunenfeld Research Institute, Mount Sinai HospitalQuality of Labour Epidural Analgesia With Intrathecal Morphine as a Component of Combined Spinal Epidural | 2026-12 |
| NCT07516171Samuel Lunenfeld Research Institute, Mount Sinai HospitalA Digital Educational Resource to Improve Preparedness for Shared Decision Making About Labour Analgesia | 2027-06 |
Add all 2 to your calendar (.ics) → With an account.
Among the 22 studies in Labor Pain by Samuel Lunenfeld Research Institute, Mount Sinai Hospital, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Combined spinal-epidural (CSE) for labor analgesia has been used for many years and is practiced commonly at our institution, especially when the patient requests immediate pain relief. CSE is not only beneficial for its faster onset of analgesia, but also it is favorable in relation to the need for rescue analgesia, urinary retention, and rate of instrumental delivery compared to the traditional epidural. Despite its beneficial effects, there is a risk of about 15-30% of developing abnormal fetal heart rate following CSE. This is self-resolving with minimal or no intervention. Although the cause of fetal bradycardia is not fully elucidated, variations in uterine artery blood flow after epidural analgesia are thought to be due to the interaction of numerous events related to blockade of sympathetic innervations, fluid administration, maternal hypotension, uterine vascular effects of sympathetic block, fluctuations in circulating catecholamines, and possibly the effect of opioids. Similar mechanism is thought to be a cause of fetal bradycardia after the CSE with its faster onset and superior block.
Maternal or fetal circulation during labor can be assessed using continuous-wave Doppler ultrasound to monitor maternal uterine artery (UtA) and fetal umbilical artery (UmA) velocity waveforms to detect changes in blood flow. The velocimetry indices mentioned above have been often used to assess the changes in the blood flow before and after the induction of epidural analgesia during labor in several studies. Although there are some studies regarding the effect of labor epidural analgesia using velocimetry indices, but there is currently no published study evaluating velocimetry indices of uterine and umbilical arteries before and after the induction of CSE. Thus, the aim of this study is to investigate the impact of CSE to maternal and fetal blood flow to evaluate the relationships.
The investigators hypothesize that both uterine artery and umbilical artery blood flow are reduced after the induction of CSE, which may be responsible for the occurrence of fetal bradycardia.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Ultrasound will be used to measure velocimetric index of the umbilical artery.
Device: Ultrasound
Ultrasound will be used to measure velocimetric index of the umbilical artery.
Device: Ultrasound
Ultrasound scan of the umbilical artery
Umbilical artery velocimetric index - systolic/diastolic ratio (S/D) at 10 minutes
Umbilical artery velocimetric index - systolic/diastolic ratio (S/D) will be measured 10 minutes after combined spinal epidural, with the uterus in relaxed and contracted states.
Time frame: 10 minutes
Umbilical artery velocimetric index - pulsatility index (PI) at 10 minutes
Umbilical artery velocimetric index - pulsatility index (PI) will be measured 10 minutes after combined spinal epidural, with the uterus in relaxed and contracted states.
Time frame: 10 minutes
Umbilical artery velocimetric index - resistance index (RI) at 10 minutes
Umbilical artery velocimetric index - resistance index (RI) will be measured 10 minutes after combined spinal epidural, with the uterus in relaxed and contracted states.
Time frame: 10 minutes
Umbilical artery velocimetric index - systolic/diastolic ratio (S/D) at baseline
Umbilical artery velocimetric index - systolic/diastolic ratio (S/D) will be measured prior to combined spinal epidural, with the uterus in relaxed and contracted states.
Time frame: 5 minutes
Umbilical artery velocimetric index - pulsatility index (PI) at baseline
Umbilical artery velocimetric index - pulsatility index (PI) will be measured prior to combined spinal epidural, with the uterus in relaxed and contracted states.
Time frame: 5 minutes
Umbilical artery velocimetric index - resistance index (RI) at baseline
Umbilical artery velocimetric index - resistance index (RI) will be measured prior to combined spinal epidural, with the uterus in relaxed and contracted states.
Time frame: 5 minutes
Umbilical artery velocimetric index - systolic/diastolic ratio (S/D) at 5 minutes
Umbilical artery velocimetric index - systolic/diastolic ratio (S/D) will be measured 5 minutes after combined spinal epidural, with the uterus in relaxed and contracted states.
Time frame: 5 minutes
Umbilical artery velocimetric index - pulsatility index (PI) at 5 minutes
Umbilical artery velocimetric index - pulsatility index (PI)will be measured 5 minutes after combined spinal epidural, with the uterus in relaxed and contracted states.
Time frame: 5 minutes
Umbilical artery velocimetric index - resistance index (RI) at 5 minutes
Umbilical artery velocimetric index - resistance index (RI) will be measured 5 minutes after combined spinal epidural, with the uterus in relaxed and contracted states.
Time frame: 5 minutes
Umbilical artery velocimetric index - systolic/diastolic ratio (S/D) at 20 minutes
Umbilical artery velocimetric index - systolic/diastolic ratio (S/D) will be measured 20 minutes after combined spinal epidural, with the uterus in relaxed and contracted states.
Time frame: 20 minutes
Umbilical artery velocimetric index - pulsatility index (PI) at 20 minutes
Umbilical artery velocimetric index - pulsatility index (PI) will be measured 20 minutes after combined spinal epidural, with the uterus in relaxed and contracted states.
Time frame: 20 minutes
Umbilical artery velocimetric index - resistance index (RI) at 20 minutes
Umbilical artery velocimetric index - resistance index (RI) will be measured 20 minutes after combined spinal epidural, with the uterus in relaxed and contracted states.
Time frame: 20 minutes
Umbilical artery velocimetric index - systolic/diastolic ratio (S/D) at 30 minutes
Umbilical artery velocimetric index - systolic/diastolic ratio (S/D) will be measured 30 minutes after combined spinal epidural, with the uterus in relaxed and contracted states.
Time frame: 5 minutes
Umbilical artery velocimetric index - pulsatility index (PI) at 30 minutes
Umbilical artery velocimetric index - pulsatility index (PI) will be measured 30 minutes after combined spinal epidural, with the uterus in relaxed and contracted states.
Time frame: 30 minutes
Umbilical artery velocimetric index - resistance index (RI) at 30 minutes
Umbilical artery velocimetric index - resistance index (RI) will be measured 30 minutes after combined spinal epidural, with the uterus in relaxed and contracted states.
Time frame: 30 minutes
Pain score at baseline - questionnaire
Pain score - verbal numeric rating scale (0-10) prior to combined spinal epidural
Time frame: 1 minute
Pain score at 10 minutes - questionnaire
Pain score - verbal numeric rating scale (0-10) at 10 minute after combined spinal epidural
Time frame: 10 minutes
Pain score at 30 minutes - questionnaire
Pain score - verbal numeric rating scale (0-10) at 30 minute3 after combined spinal epidural
Time frame: 30 minutes
Sensory block level at 10 minutes
Sensory block level at 10 minutes following combined spinal epidural
Time frame: 10 minutes
Sensory block level at 30 minutes
Sensory block level at 30 minutes following combined spinal epidural
Time frame: 30 minutes
frequency of uterine contractions
The number of contractions on the monitor in a 10 minute period.
Time frame: 10 minutes
Presence of prolonged hypertonic uterine contractions- questionnaire
Presence of prolonged hypertonic uterine contractions as measured by the monitor
Time frame: 30 minutes
Hypotension: systolic blood pressure less than 80% of baseline
Systolic blood pressure \< 80% of baseline, monitored q5 for 30 minutes following combined spinal epidural
Time frame: 30 minutes
Hypertension: systolic blood pressure greater than 120% of baseline
Systolic blood pressure \> 120% of baseline, monitored q5 for 30 minutes following combined spinal epidural
Time frame: 30 minutes
Bradycardia: heart rate less than 70% of baseline
Heart rate \< 70% of baseline or a heart rate \< 50bpm, monitored q5 for 30 minutes following combined spinal epidural
Time frame: 30 minutes
Desaturation: oxygen level <95%
Oxygen level \<95%, monitored q5 for 30 minutes following combined spinal epidural
Time frame: 30 minutes
fetal heart rate at baseline
fetal heart rate at baseline, prior to combined spinal epidural
Time frame: 5 minutes
fetal heart rate q5 min up to 30 minutes
fetal heart rate q5 min up to 30 minutes following combined spinal epidural
Time frame: 30 minutes
presence of fetal bradycardia - questionnaire
presence of fetal bradycardia (fetal heart rate \<110)
Time frame: 30 minutes
presence of fetal prolonged deceleration - questionnaire
presence of fetal prolonged deceleration (fetal heart rate \<110/min lasting less than 10 minutes)
Time frame: 30 minutes
presence of fetal persistent late decelerations - questionnaire
presence of fetal persistent late decelerations will be recorded
Time frame: 30 minutes
presence of fetal non-reassuring variable deceleration - questionnaire
presence of fetal non-reassuring variable deceleration will be recorded
Time frame: 30 minutes
presence of fetal salutatory variability - questionnaire
presence of fetal salutatory variability (FHR change\>25beats) will be recorded
Time frame: 30 minutes
Neonatal weight
Neonatal weight measured after delivery in grams minutes
Time frame: up to 24 hours
Apgar score at 1 minute
Apgar score at 1 minute
Time frame: 1 minute
Apgar score at 5 minutes
Apgar score at 5 minutes
Time frame: 5 minutes
Mode of delivery - questionnaire
Mode of delivery will be recorded as vaginal, assisted (forceps or vacuum), or cesarean
Time frame: up to 24 hours
Plan to share: No
No publications or documents are linked to this record.
Started Oct 2024 (actual). Primary completion is estimated for Dec 2027, 38 months after the start.
Of 192 non-industry interventional studies with no phase under Labor Pain, half reached primary completion within 9 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 14. This study's planned 38 months is above that.
Counting every sponsor, half of 194 studies reached it within 9 months; a quarter within 5 and three quarters within 14.
Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 16, 2026: primary completion Jan 2026 → Dec 2027 and completion Jan 2026 → Dec 2027.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Samuel Lunenfeld Research Institute, Mount Sinai Hospital →